China · Delayed Price · Currency is CNY Jiangsu CoWin Biotech Company Description
Jiangsu CoWin Biotech Co., Ltd. engages in the research, development, sales, testing, and technology services of biological reagents in China.
The company offers RT-PCR, PCR, multiplex PCR, and qPCR; collection, such as cfDNA, fecal DNA, saliva DNA, and urine DNA storage tube, as well as other collection products; cfDNA, genomic DNA, FFPE DNA extraction, and plasmid kit; molecular raw materials; quantitative analysis, RNA sequencing, adapter, purification magbeads, DNA sequencing, and single cells sequencing products; molecular cloning, such as cloning reagents; nucleic acid residue and contamination screening reagent; and other products.
It also provides gene synthesis, gene fragment, and codon optimization services. The company’s products and services are used in infectious disease, eugenics and good parenting, and oncology applications.
The company was founded in 2007 and is headquartered in Taizhou, China.
| Country | China |
| Founded | 2007 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 769 |
| CEO | Chun Xiang Wang |
Contact Details
Address: No. 18, Zelan Road Taizhou, 225311 China | |
| Phone | 86 523 8620 1352 |
| Website | cwbio.com |
Stock Details
| Ticker Symbol | 688426 |
| Exchange | Shanghai Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE100005NM2 |
| SIC Code | 2835 |
Key Executives
| Name | Position |
|---|---|
| Zhihua Zhuang | Deputy GM and Director |
| Yubai Qi | Deputy GM, Board Secretary and Director |
| Dr. Chun Xiang Wang | GM and Chairman |
| Li Huang | Accounting Supervisor |